World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00136812
Date of registration: 25/08/2005
Primary sponsor: University of California, San Francisco
Public title: Treating Tobacco Dependence in Inpatient Psychiatry - 1
Scientific title: Treating Tobacco Dependence in Inpatient Psychiatry
Date of first enrolment: July 2006
Target sample size: 300
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00136812
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Judith Prochaska
Address: 
Telephone:
Email:
Affiliation:  University of California, San Francisco
Key inclusion & exclusion criteria

Inclusion Criteria:

Men and women over 18 years of age hospitalized on an inpatient psychiatric unit who
report smoking at least 5 cigarettes per day. Other inclusion criteria include: smoking at
least 100 cigarettes in one's lifetime, residing in the San Francisco Bay Area with no
plan to relocate outside of the area in the next 18 months, and access to a telephone for
scheduling follow up assessments.

Exclusion Criteria:

Dementia or other brain injury precluding ability to participate; non-English speaking;
severe agitation, psychosis, or hostility; and medical contraindications to nicotine
replacement therapy (NRT). Recruitment of acutely psychotic, manic, or hostile patients
will be delayed until there is significant reduction of these symptoms. Medical
contraindications are: myocardial infarction in the preceding 3 months, unstable angina
pectoris, liver or kidney disease, current pregnancy or breast feeding, allergies to
adhesives, or other medical conditions that the medical team deems incompatible with NRT
use.



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Tobacco Use Cessation
Tobacco Use Disorder
Intervention(s)
Behavioral: Tobacco Use Cessation
Primary Outcome(s)
7 day point prevalence of cigarette abstinence [Time Frame: 1 week, 3 mo, 6 mo, 12 mo, and 18 mo post-baseline]
Secondary Outcome(s)
Secondary ID(s)
5K23DA018691-05
K23-18691-1
NIDA-18691-1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Institute on Drug Abuse (NIDA)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history